A review on the application of high‐field asymmetric waveform ion mobility spectrometry (FAIMS) in drug discovery
2008; Wiley; Volume: 22; Issue: 5 Linguagem: Inglês
10.1002/rcm.3416
ISSN1097-0231
AutoresPanos Hatsis, James T. Kapron,
Tópico(s)Pesticide Residue Analysis and Safety
ResumoRapid Communications in Mass SpectrometryVolume 22, Issue 5 p. 735-738 Letter to the Editor A review on the application of high-field asymmetric waveform ion mobility spectrometry (FAIMS) in drug discovery Panos Hatsis, Corresponding Author Panos Hatsis [email protected] Department of Drug Metabolism and Pharmacokinetics, Millennium Pharmaceuticals Inc., 35 Landsdowne St., Cambridge, MA 02139, USA Panos Hatsis, Department of Drug Metabolism and Pharmacokinetics, Millennium Pharmaceuticals Inc., 35 Landsdowne St., Cambridge, MA 02139, USA. James T. Kapron, Thermo Fisher Scientific, 5716 Coopers Ave, Unit 1, Mississauga, ON, Canada, L4Z 2E8.Search for more papers by this authorJames T. Kapron, Corresponding Author James T. Kapron [email protected] Thermo Fisher Scientific, 5716 Coopers Ave, Unit 1, Mississauga, ON, Canada, L4Z 2E8 Panos Hatsis, Department of Drug Metabolism and Pharmacokinetics, Millennium Pharmaceuticals Inc., 35 Landsdowne St., Cambridge, MA 02139, USA. James T. Kapron, Thermo Fisher Scientific, 5716 Coopers Ave, Unit 1, Mississauga, ON, Canada, L4Z 2E8.Search for more papers by this author Panos Hatsis, Corresponding Author Panos Hatsis [email protected] Department of Drug Metabolism and Pharmacokinetics, Millennium Pharmaceuticals Inc., 35 Landsdowne St., Cambridge, MA 02139, USA Panos Hatsis, Department of Drug Metabolism and Pharmacokinetics, Millennium Pharmaceuticals Inc., 35 Landsdowne St., Cambridge, MA 02139, USA. James T. Kapron, Thermo Fisher Scientific, 5716 Coopers Ave, Unit 1, Mississauga, ON, Canada, L4Z 2E8.Search for more papers by this authorJames T. Kapron, Corresponding Author James T. Kapron [email protected] Thermo Fisher Scientific, 5716 Coopers Ave, Unit 1, Mississauga, ON, Canada, L4Z 2E8 Panos Hatsis, Department of Drug Metabolism and Pharmacokinetics, Millennium Pharmaceuticals Inc., 35 Landsdowne St., Cambridge, MA 02139, USA. James T. Kapron, Thermo Fisher Scientific, 5716 Coopers Ave, Unit 1, Mississauga, ON, Canada, L4Z 2E8.Search for more papers by this author First published: 13 February 2008 https://doi.org/10.1002/rcm.3416Citations: 46Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume22, Issue515 March 2008Pages 735-738 RelatedInformation
Referência(s)